Clinical Trials & Research Studies
Breast cancer clinical trials, also called clinical studies, are a type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis or treatment.
In this section, get basic information about breast cancer clinical trials for African-American women diagnosed with breast cancer, explore whether taking part in a clinical trial is right for you and find studies you may be eligible to participate in.
You can also get information and updates on other breast cancer research studies that follow participants over time to determine treatment outcomes.
Researchers seek young African-American women with multiple family members who have been diagnosed with breast cancer to help them discover unique genes that may ultimately help lead to better research and treatments.
If you live in the Houston area and finished breast cancer treatment at least one year ago but not more than five years ago, we invite you to test a program to help women deal with sexual problems or concerns about fertility after cancer.
If you are affected by early-stage breast cancer that has been indicated to have a high risk of recurrence, find out whether you are eligible to participate in the D-CARE clinical trial, which is considering the impact of denosumab as an adjuvant treatment for Stage II and Stage III breast cancer.
Researchers seek women newly diagnosed with stage I-III breast cancer planning to undergo axillary lymph node dissection for a study on preventing and treating lymphedema.
If you are newly diagnosed, find out whether you are eligible to participate in I-SPY2, a trial measuring the effectiveness of adding new medicines to standard chemotherapy given before surgery.
Phase III trial will compare lapatinib and trastuzumab in preventing recurrence of early-stage, HER2 positive breast cancer after surgery and chemotherapy.
SWOG-S0500 is a clinical trial studying whether women with high levels of circulating tumor cells who switch medicines after their first chemotherapy treatment live longer than those who do not.